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The acetylator phenotype of 180 children aged
3-11 years was determined on the basis of isoniazid
concentrations in saliva collected at 5 hours after
oral administration of body-weight and surface-
area-related &sages of the drug in a syrup form.
isoniazid 25 mglkg was administered on one occa-
sion and 75 mg/m2 surface-area on another, with
an interval of 3 days between the occasions. A
cross-over design was employed and the sequence
was determined by random allocation. The dis-
tribution of the concentrations was bimodal with
both procedures, indicating the presence of two
groups namely, the slow and rapid acetylators. The
criterion for a rapid acetylator was a concentration
of 0.3 µg/ml or less by body-weight-related dosage
and 0.4 µg/ml or less by that based on surface-area.
Based on these criteria, 62 % of the children were
classified as slow acetylators and 38% as rapid
acetylators by body-weight, and 59 and 41 %,
respectively by surface-area, and the findings were
similar in children in the different age-groups. The
agreement between the two procedures was 98%.
Key words: Acetylator phenotype of children,
Salivary concentrations of isoniazid,
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Information on the determination of
acetylator phenotype of children is scarce,
mainly due to difficulties in obtaining
multiple blood specimens and timed urine
collections from these subjects. A few
investigators employing body-weight-
related dosages of isoniazid, have reported
a higher proportion of rapid acetylators
among children than among adults of the
same race(1-4). Isoniazid acetyltrans-
ferase, the concentration of which deter-
mines the speed of acetylation, is a consti-
tutive enzyme and is not inducible; there-
fore, the proportions of slow and rapid
acetylators in children should not be
different from those in the adult popula-
tion. It has been suggested that the
age-related differences in the proportions
of slow and rapid acetylators could pos-
sibly be due to the administration of
inappropriate body-weight-related dosages
and that the dosages should be based on
body-surface-area instead, particularly in
children aged less than 5 years (2,5)
To the best of our knowledge, no investi-
gations have been undertaken so far to
compare the distributions obtained with
the two procedures.
We have recently demonstrated that
salivary concentrations of isoniazid are
similar to those in serum(6), and that the
concentrations in saliva at 5 hours fol-
lowing a uniform oral dose of isoniazid
100 mg could effectively discriminate
between slow and rapid acetylators of the
drug among adult subjects(7). An in-
vestigation was therefore undertaken to
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determine the acetylator phenotype of
children aged 3-11 years (completed
years) on the basis of concentrations in
saliva at 5 hours following administra-
tion of the drug dosages based on body-
weight as well as surface-area; this report
presents the findings.
Material and Methods
Subjects: Healthy children aged 3-11
years and residing in Choolai, an urban
crowded locality in Madras city, where
a survey for the prevalence of tuberculosis
was in progress were included in the
study.
Calculation of the dosages of isoniazid:
Calculation of body-weight and surface-
area-related dosages of isoniazid to be
employed in children was based on the
successful experience in the classification
of adult patients with pulmonary tuber-
culosis as slow or rapid acetylators on the
basis of concentrations of isoniazid in
saliva following a uniform oral dose of
isoniazid 100 mg(7).
The mean body-weight, height and
surface-area of 230 consecutive adult
patients were 40.6 kg, 160.2 cm and
1.32 m2 respectively, the surface-area
having been calculated using the for-
mula(8):
log A = 0.725 log H + 0.425 log W – 2.144
where A=surface-area (m2), H=height
(cm) and W=body-weight (kg). If a test
dose of isoniazid 100 mg were to be used,
the mean dosages based on body-weight
and surface-area would work out to be
2.46 mg/kg and 74.6 mg/m2, respectively.
Therefore, for investigations in children,
the dosages employed were 2.5 mg/kg
body-weight and 75 mg/m2 surface-
area.
Design of the investigation: The children
were classified as slow or rapid acety-
lators on the basis of distributions of
concentrations of isoniazid in saliva at
5 hours following oral administration of
isoniazid 2.5 mg/kg body-weight on one
occasion and 75 mg/m2 surface-area on
another occasion, with an interval of at
least 3 days between the occasions. A
cross-over design was employed and the
sequence was determined by random
allocation.
Conduct of the investigation: Adminis-
tration of isoniazid and the collection of
saliva were carried out in the Corpora-
tion Health Unit. The children were
visited in their homes by field workers
and given appointments to report to the
health unit by 7 a.m. in a fasting state on
the two days. Body-weight (kg) and
height (cm) were recorded by field
workers trained in anthropometry. After
verifying that urine was negative for
acetylisoniazid(9), isoniazid was adminis-
tered in the form of syrup (“Isokin”
stated content: 20 mg/ml) on the basis of
separate dosage schedules based on body-
weight (Table I) and a nomogram relat-
ing the dosage to height-weight measure-
ments (Table II) for surface-area. The
order in which the child received the body-
weight or surface-area-related dose
was by random allocation, which was
supplied to the field workers in the form
of a chart. The required volume of the
syrup was delivered directly into the gullet
(to avoid contamination of the oral cavity)
with the help of a syringe, with graduation
intervals of 0.2 ml, to which a siliconized
rubber tubing was attached. The syringe
and the tube were rinsed once with a few
ml of water and the rinsings were also
delivered into the gullet the same way.
The children were asked to report to the
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TABLE I– Dosage Schedule Based on Body-weight
(2.5 mg/kg)
Body-weight
(kg)
< 5.0
5.1-10.0
10.1-15.0
15.1-20.0
20.1-25.0
25.1-30.0
30.1-35.0
35.1-40.0
Volume (ml) of
syrup to be
administered*
0.4
1.0
1.6
2.2
2.8
3.4
4.0
4.8
40.1-45.0 5.4
> 45.0 6.0
*Isokin syrup (stated content: 20 mg/ml)
heal th  uni t  about  4½ hours  la ter .
About 10 minutes before the scheduled
time of collection at 5 hours, they were
asked to wash their mouth thoroughly.
To facilitate salivary secretion, the
children were asked to chew a piece of
unsweetened, unflavoured chewing gum
and to spit out the initial salivary secre-
tion. About 5 ml of saliva were then
collected over 5-10 minutes in a universal
container.
The saliva samples were sent soon
after collection to the Tuberculosis Re-
search Centre where they were kept frozen
at –20°C overnight. The samples were
then thawed and centrifuged, the residue
containing mucoproteins discarded, and
the clear supematants were stored at
–20°C for not more than 48 hours.
Isoniazid concentrations in the salivary
supernatants were determined by a spec-
trophotometric method(10) after coding
the samples. In brief, isoniazid was
extracted from the salivary supernatants
(3 ml) with a mixture of chloroform and
n-butanol(7 : 3) and re-extracted into 0.1N
sulphuric acid. The acid extract was
reacted with a 2% solution of vanillin
in 25 % ethanol and the extinction recorded
at 380 nm using microcells of 2 cm path-
length. The sensitivity of the method
is 0.1 µg/ml and none of the metabolites
of isoniazid namely, acetylisoniazid, iso-
nicotinic acid, isonicotinylglycine, mono-
and diacetylhydrazines nor any of the
commonly used anti-tuberculosis drugs
interfered with the estimation of
isoniazid.
Results
A total of 182 children were studied.
Findings from 2 of these were excluded
from the analysis; the urine of one child
was positive for acetylisoniazid and one
child failed to turn up for the second
occasion. Of the remaining 180 children
in the analysis, 57 were in the 3-5 year
age group, 66 in the 6-8 year age group
and 57 were aged 9-11 years.
The mean body-weight, height, surface-
area and doses of isoniazid administered
are presented in Table III. The dose of
isoniazid (mg) administered was always
higher by the dosage based on surface-
area than that based on body-weight,
the differences being 31, 30 and 24% in
the 3-5, 6-8 and 9-11 year age groups,
respectively.
The distributions according to the
concentrations of isoniazid in saliva at
5 hours with the two procedures are
presented in the form of histograms in
the Fig. Both the distributions are
bimodal indicating the presence of two
groups of children, namely the slow and
rapid acetylators. On the basis of these
histograms, the criterion for a rapid
acetylator was taken to be a concen-
tration of 0.4 µg/ml or less by surface-area
and 0.3 µg/ml or less by body-weight.
Based on these criteria, of the 180 children.
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TABLE II– Dosage Schedule Based on Surface-area (75 mg/m2)–Nomogram Relating the Dose to
Height- Weight Measurements
Height
(cm)
Volume (ml) of syrup* to be administered for the following weight categories (kg)
< 5.0 5.1-10.0 10.1-15.0 15.1-20.0 20.1-25.0 25.1-30.0 30.1-35.0 35.1-40.0 > 40.0
< 80.0 1.0* 1.4 1.8 2.2 2.4 2.6 2.8 3.0 3.2
80.0-89.9 1.0 1.6 2.0 2.4 2.6 2.8 3.0 3.2 3.4
90.0-99.9 1.2 1.8 2.2 2.6 2.8 3.0 3.2 3.4 3.6
100.0-109.9 1.2 1.8 2.4 2.8 3.0 3.2 3.6 3.8 4.0
110.0-119.9 1.2 2.0 2.6 2.8 3.2 3.4 3.8 4.0 4.2
120.0-129.9 1.4 2.2 2.6 3.0 3.4 3.8 4.0 4.2 4.4
130.0-139.9 1.4 2.2 2.8 3.2 3.6 4.0 4.2 4.4 4.8
*Isokin syrup (stated content 20 mg/ml).
TABLE III– Mean Body-weight, Height, Surface-area and Doses of Isoniazid Administered
No. of Body-weight
children (kg)
Height
(cm)
Surface..
area
(m2)
Dose of isoniazid administered
(mg)
by by
body-weight* surface-area*
3- 5 57 13.7** 97.9 0.61
(11.1-18.1) (53.8-111.8) (0.50-0.75)
6 - 8 66 17.5 113.7 0.75
(12.5-25.0) (101.6-128.8) (0.61-0.96)
9-11
All
groups
57 22.3 126.7 0.90
(15.4-32.1) (107.6-145.1) (0.68-1.15)
180 17.8 112.8 0.75
(I 1.1-32.1) (53.8-145.1) (0.50-1.15)
* 2.5 mg/kg body-weight and 75 mg/m2 surface-area.
** Mean, with range in parentheses.
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Fig. Distribution of 180 children according to the concentrations of isoniazid in saliva
at 5 hours after oral administration of surface-area and body-weight-related dosages
of the drug.
73 (41%), were classified as rapid acety-
lators by surface-area and 69 (38%)
by body-weight, the proportions of slow
acetylators being 59 and 62%, res-
pectively. The classification by the two
procedures was the same in 176 of the
180 children, leading to an agreement
o f  9 8 % .  
The mean isoniazid concentrations in
saliva in slow and rapid acetylators and
the indices of discrimination (i.e., the
ratio of the difference between the mean
values in slow and rapid acetylators to
its standard error) and the proportions
of the two phenotypes according to the
age group of the children by the two
procedures are given in Table IV. The
mean concentrations of isoniazid were
appreciably higher in the slow than in the
rapid acetylators. The proportions of
the two phenotypes were similar in the
different age groups by both procedures.
The index of discrimination by the pro-
 cedure based on surface-area was higher
than that based on body-weight in all
age groups. Corresponding to the higher
dose received with the surface-area-related
dosage, the mean isoniazid concentration
in the 180 children (amalgamating the
findings in slow and rapid acetylators) was
0.62 µg/ml, which was significantly higher
(p<0.001) than that based on body-
weight (0.47 µg/ml). The differences
between the mean values by the two pro-
cedures decreased with increase in age, the
mean differences being 0.20, 0.15 and 0.12
µg/ml in the 3-5, 6-8 and 9-11 year age
groups, respectively.
Discussion
Use of saliva, where applicable, has
obvious practical advantages, particularly
in children, as the procedure is non-
invasive, amenable for collection of multi-
ple specimens, and also permits the conduct
of the investigations under field condi-
tions. Indeed, this investigation, em-
ploying a randomised cross-over design
for drug administration and the collection
of saliva on two different occasions was
successfully carried out in a field area.
Results presented in this report demons-
trate that the test based on the deter-
mination of isoniazid concentrations in
saliva at 5 hours after administration of
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TABLE IV– Mean Isoniazid Concentrations, Proportions Classified as Slow or Rapid Acetylators
and the Indices of Discrimination
Age
group
(years)
3-5
No. of
children
57
By body-weight
Mean INH concentrations
(µg/ml)
Slow Rapid
0.68 0.12
(61)* (39)*
Index of
discrimi-
nation
11.6
By surface-area
Mean INH concentrations
(µg/ml)
Slow Rapid
0.99 0.19
(58) (42)
Index of
discrimi-
nation
13.8
6-8 66 0.69 0.09 18.8 0.93 0.14 19.3
(61) (39) (59) (41)
9-11 51 0.72 0.10 14.9 0.91 0.15 16.2
(63) (37) (61) (39)
All 180 0.70 0.10 25.6
groups (62) (38)
*Figures in parentheses indicate the proportions (%) of slow or rapid acetylators.
0.94 0.16 28.0
(59) (41)
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body-weight or surface-area-related do-
sages of isoniazid can be successfully
employed for classifying children as slow
or rapid acetylators.
Several studies undertaken in 3,000
adult South Indian patients with pul-
monary tuberculosis at our Centre(11)
have shown that the proportions of rapid
acetylators ranged from 32 to 46 % (mean
41%). In the present study in 180 children
aged 3-11 years, the proportions of rapid
acetylators were 41 % by the dosage based
on surface-area and 38% by that based
on body-weight, proportions very similar
to those obtained in adult subjects. Even
though the index of discrimination by
surface-area is higher than that by body-
weight in all age groups, employing the
latter procedure would be more con-
venient as it avoids measurement of the
height and the calculation of body-surface-
area. However, the criterion adopted
to discriminate between the two pheno-
types must be based on distributions
obtained in children and not that derived
from adult population. This may be
illustrated by comparing the distributions
obtained in adult subjects(7) and in
children (present study). The criterion for
a rapid acetylator in 150 adults employ-
ing a uniform oral dose of 100 mg (mean
dosage 2.25 mg/kg) was a concentration
of 0.4 µg/ml or less. If this criterion were
to be applied in the present study in
children, 5 slow acetylators would be mis-
classified as rapid acetylators even though
the dosage received (2.5 mg/kg) was higher
than that in the adults. A similar ob-
servation has been made by Bartmann
and Massmann(12) who compared the
distributions of serum isoniazid concen-
trations following an oral dose of iso-
niazid 5 mg/kg in 39 children and 295
adults, the criteria to distinguish the two
phenotypes being 0.3 and 0.5 µg/ml.
respectively.
In a recent study, Bajaj et al. (4) deter-
mined the acetylator phenotype of 276
children based on plasma isoniazid con-
centrations at 5 hours following an intra-
muscular dose of isoniazid 10 mg/kg.
They observed a trimodal distribution
and classified 17% of their subjects as
fast, 63 % as intermediate and 20% as
slow acetylators of isoniazid. Since slow
acetylators are homozygous for the
recessive gene and rapid acetylators could
b e  e i t h e r  homozygous or heterozygous
for the dominant gene(13), it follows that
80% of the children investigated are rapid
acetylators. They have not-mentioned the
proportion of rapid acetylators among
adult subjects of their region, but it will
be surprising if a proportion of greater
than 50% is observed. The main diffe-
rence between our study and that of
Bajaj et al. (4), apart from the dosages
and the body-fluid employed, is that the
age of their children was 1-12 years while
that in our study group, was 3-11 years.
It will be interesting to find out if they
had observed any differences in the pro-
portions of slow and rapid acetylators
in the different age groups, particularly
in children aged less than 3 years.
Children less than 3 years of age were
not investigated in the present study
due to difficulties in obtaining adequate
volumes of saliva from these subjects.
However, more sensitive methods such
as those based on spectrofluorimetry or
high-pressure liquid chromatography
(which require smaller volumes of saliva)
can be employed for determination of
isoniazid concentrations even in these
children. The dosage may, however, have
to be based on surface-area rather than
on body-weight for efficient discrimina-
tion, as results presented in this paper
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show an increase in the mean difference 5.
in isoniazid concentrations between the
two procedures with a decrease in age,
and the difference between the indices 6.
of discrimination was highest in the
youngest age group (3-5 years).
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